Patient Care Online

Updated Guidelines for Atrial Fibrillation from ACC/AHA Focus on Aggressive Prevention and Control and a Continuum of Care

December 1st 2023

Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.

Treatment for Cluster Headache: European Academy of Neurology Guidelines

December 1st 2023

The revised guidance classifies AF into 4 stages, emphasizes prevention and aggressive rhythm control, and upgrades recommendations for catheter ablation and LAA occlusion.

By Steven A. King, MD, MS

Migraine & Hypertension: What is the Connection?

Cluster headache is rare and can be disabling. It can be misdiagnosed, particularly as migraine, but treatments are very different. Learn more in a short slide show.

By Susan Hutchinson, MD

Daily Dose: Lung Cancer Screening Significantly Increases Long-Term Survival Rate

Which antihypertensive therapy options are most and least effective for patients with migraine? Get details, here.

Risk Stratification for Preeclampsia Would Save Lives, Reduce Burden of Cost to Health Care System

Your daily dose of the clinical news you may have missed.

More Informed Management of Preeclampsia Is Necessary Rebecca Khan, MD image credit Thermo Fisher Scientific

By Rebecca T Khan, MD

Obesity Advocacy Groups Say Exclusion of People with Obesity from Drug Research Must Stop

Identifying women at risk for preeclampsia with severe features and the most effective treatment is essential to reduce morbidity as well as to contain costs.

Underestimation of OHE Hospitalizations: Author of New Study Discusses Clinical Implications, Takeaways for Primary Care Clinicians

The 5 leading advocacy groups said the safety of people with obesity is at risk and called on the FDA to change clinical trial inclusion requirements and expedite labeling changes.

Daily Dose: COVID-19, Opioid Epidemic Primary Drivers of Widening Gender Gap in Life Expectancy

Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.

Primary Prevention of ASCVD: A Guideline Topline for Primary Care

Your daily dose of the clinical news you may have missed.

By Kenneth Bender, PharmD, MA

Treat the Neuropathic Pain—and the Rest of the Person, Too: PM&R Physician Saloni Sharma, MD

Review the ACC/AHA guidelines on prevention of ASCVD through lifestyle and risk factor assessment and management in our at-a-glance slide show.

Lung Cancer Survival Improved Significantly Based on Early CT Screening: 20-Year Follow-Up Study Findings

Physiatrist Saloni Sharma, MD, stresses the essential role of coordinated, multidisciplinary care for a person with neuropathic pain—and any person with limited function.

Early CT Screening Significantly Improves Survival in Lung Cancer image credit ©nerthuz/stock.adobe.com

By Rina Lokaj

November 28th 2023

Early CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.

CV Risk Factors Increasing Among Middle-Aged US Adults, Socioeconomic Inequities Persist: New Findings

Dupilumab sBLA Submission for COPD Accelerated Based on Second Positive Phase 3 Trial Findings

November 28th 2023

Cardiovascular mortality has been increasing among middle-aged US adult since 2011; a new study looked at changes in CV risk factors by income level over the past 20 years.

Abdominal Bloating Morphs into Pain and Vomiting: Seen in the ED

November 27th 2023

Dupilumab reduced COPD exacerbations by more than one-third in the phase 3 NOTUS trial, matching outcomes from the earlier BOREAS study this year.

small bowel obstruction, Seen in the emergency department / image credit ©Guschenkova/stock.adobe.com

By Brady Pregerson, MD

November 27th 2023

A 62-year-old woman reports several days of abdominal bloating and vomiting that changed 2 hours ago into severe generalized pain. Review the bedside ultrasound, here.

Daily Dose: Lowering SBP to <120 mm Hg Reduces CV Event Risk

How to Build Assessment for Cardiovascular-Kidney-Metabolic Syndrome into Primary CVD Prevention

November 22nd 2023

Your daily dose of the clinical news you may have missed.

Use Weight-First Approach to Educate Patients about Obesity’s Role in HTN

November 22nd 2023

Chiadi Ndumele, MD, PhD, MHS, offers 3 thoughts for primary care on incorporating CKM syndrome screening into daily clinical practice.

Physiatry's Focus on the Whole Person and Collaborative Care is an Ideal Rx for Neuropathic Pain

An obesity specialist discusses the importance of using a weight-first approach when educating patients about obesity's role in the development and worsening of hypertension.

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis, According to New Research

According to physical medicine and rehabilitation physician Saloni Sharma, MD, treatment for neuropathic pain draws on PM&R's many strengths.

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis / Image credit: ©wissanustock/AdobeStock

Daily Dose: Speech is Promising Biomarker for MHE and OHE

Investigators found that the gender life expectancy gap increased 0.23 years from 2010 to 2019 and 0.70 years from 2019 to 2021.

Phase 3 Trial of Factor XIa Inhibitor Asundexian Halted for Lack of Efficacy

Your daily dose of the clinical news you may have missed.

Primary Care is the Quarterback in Effective Care for Cardiovascular-Kidney-Metabolic Syndrome

The novel oral anticoagulant is one in a class of agents for prevention of AF-related stroke that shows promise to reduce bleeding risk.

New CVD Risk Equations are Sex-Specific, Exclude Race, Include eGFR, and Predict Heart Failure

"Primary care physicians... really are like the quarterbacks" for initiating multidisciplinary care for CKM syndrome, says Dr Chiadi Ndumele.

Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM

November 20th 2023

Absolute risk assessment for CVD remains the corner-stone of clinical primary prevention efforts. The new AHA prediction models expand that foundation.